What separates joint preservation from joint replacement

Two fundamentally different things can be done for a damaged joint: preserve it, or replace it. Joint preservation covers every intervention — from exercise and weight management through injections, cartilage repair, and realignment surgery — that keeps a patient's own bone and cartilage in place. Joint replacement (arthroplasty) removes the worn joint surfaces entirely and substitutes them with a prosthesis, typically metal and polyethylene. The patient's biological joint is gone; a durable mechanical substitute takes its place.

Thinking about these options as a spectrum helps. The four stages — Preserve, Repair, Regenerate, Replace — run in sequence, and replacement sits at the far end, not because it is inferior, but because it is the appropriate answer for the point when no viable native tissue remains. For most patients, that point arrives later than they realise.

The practical problem is that many patients first hear about replacement before preservation options have been discussed at all. A 2023 survey of knee specialists in the Netherlands found that advanced cartilage repair was offered by only a small minority of practitioners, suggesting that what a patient is offered often reflects local availability rather than the full clinical picture. This article addresses that gap — not to suggest that replacement is always avoidable, but to ensure the earlier stages of the spectrum have been genuinely considered before the final step is taken.

Why your age at replacement changes the risk picture

The numbers from a large UK study, published in The Lancet, make the timing argument concrete. A man in his early fifties who undergoes knee replacement carries approximately a 35% lifetime risk of needing revision surgery — the complex, often more demanding operation required when an implant fails, loosens, or wears out. For someone over seventy undergoing the same procedure, that figure falls to around 5%. The gap exists largely because implants have a finite lifespan and younger patients simply live longer with them.

Revision arthroplasty is not a straightforward repeat. It typically requires removing the original components, managing bone loss around the implant site, and fitting larger or more constrained hardware — a procedure that carries higher complication rates and, on average, delivers worse functional outcomes than the first operation.

That asymmetry is a central reason why international specialist consensus supports attempting preservation before replacement wherever disease staging allows. The recommendation is not based on sentiment about keeping one's own joint; it is grounded in the downstream mathematics of what happens when a relatively young patient uses up their primary replacement.

Younger patients, and those whose damage is focal rather than diffuse, stand to gain most from a preservation-first assessment — precisely because they face the longest implant horizon and, by extension, the greatest revision exposure. The more pressing question, then, is what the preservation toolkit can realistically offer before that replacement decision needs to be made.

The range of preservation treatments available

Preservation is not a single treatment — it is a layered set of options organised around how much structural damage exists and what the joint's own biology can still do.

Load management and lifestyle

NHS guidance positions exercise and weight management as the most important first-line measures for osteoarthritis. Regular, appropriately guided activity builds periarticular muscle, reduces mechanical load across cartilage, and slows degradation without worsening symptoms. These are not placeholders waiting to be replaced by 'real' treatment; they are active joint protection.

Injection-based support

Two injectable pathways address the joint environment through different mechanisms. The ChondroFiller injection — an ultrasound-guided outpatient injectable collagen scaffold — places a type I/III collagen matrix into a focal defect, where the patient's own progenitor cells migrate in to lay down new cartilage matrix. Arthrosamid is a polyacrylamide hydrogel that cushions the osteoarthritic knee; its mechanism is non-regenerative, making it a distinct option rather than an alternative version of the same approach.

Cartilage restoration procedures

Where a defect requires structural repair, several options exist at varying levels of complexity. MACI and ACI are cell-based, two-stage procedures: the patient's own chondrocytes are harvested, expanded in a laboratory, and reimplanted; in the SUMMIT trial, MACI outperformed microfracture on pain and function at both two and five years. STACi is an emerging single-stage ACI variant. AMIC (matrix-augmented microfracture) offers a single-stage bridge between marrow stimulation and full cell-based repair. OATS and mosaicplasty transfer osteochondral plugs for smaller focal defects, typically up to around 4 cm².

Microfracture has a historical role but current evidence shows fibrocartilage breakdown by two to three years and subchondral bone plate damage that can compromise future repair options — it is not a modern first-line recommendation.

Realignment surgery

High tibial or distal femoral osteotomy (HTO/DFO) corrects mechanical alignment to offload the diseased compartment. It can be used alone or alongside cartilage repair in younger patients with unicompartmental disease where malalignment is contributing to the load pattern.

A 2023 survey of knee specialists in the Netherlands found that advanced cartilage repair was offered by only a minority of practitioners — meaning patients may need to ask explicitly whether a preservation assessment has been part of their workup.

Which patients are most likely to benefit from preservation

Suitability for preservation hinges on three questions a specialist asks during any structured assessment: how large is the defect, how diffuse is the disease, and is the joint's mechanical environment viable for repair?

The ideal candidate has a focal, contained cartilage lesion — damage confined to a defined area rather than spread across the joint surface — in a knee or hip that is otherwise structurally sound. Defect size is a practical guide to which technique applies. Smaller lesions under approximately 2–4 cm² are generally within range for mosaicplasty or OATS; the ChondroFiller injection is indicated for focal defects up to 3 cm², extendable to 6 cm² on clinical evaluation. Lesions in the 2–10 cm² range tend to respond better to cell-based repair: in the SUMMIT trial, MACI produced meaningfully improved KOOS pain and function scores compared with microfracture at both two and five years, a finding particularly relevant for patients with larger defects who might otherwise be offered only a marrow-stimulation technique. Very large or post-traumatic defects may require osteochondral allograft.

Kellgren–Lawrence grade 4 disease — bone-on-bone contact, significant deformity, instability, or multiple pain-generating compartments — is where preservation gives way to replacement as the clinically honest answer. Preservation techniques are designed for joints with intact or partially intact architecture, not for end-stage, diffuse osteoarthritis. This distinction matters, because false hope about preservation suitability does patients no favours.

Age is relevant but not the deciding factor. Patients under 50 with focal defects have stronger evidence supporting preservation over early arthroplasty. In older patients with diffuse disease, well-timed replacement may be the more straightforward path.

It is also worth being direct about recovery: cartilage repair procedures require a genuine commitment to structured rehabilitation, often over several months. Willingness and capacity to follow a protected recovery programme is part of honest patient selection, not an afterthought.

Suitability can only be confirmed after full imaging review — typically MRI alongside clinical examination — since the characteristics that determine the right approach are not reliably visible without it.

How to slow joint damage before it reaches a surgical threshold

Slowing joint damage is most effective before symptoms become established — once cartilage is substantially lost, the options shift from prevention to repair or replacement, and the field of available techniques narrows accordingly.

The evidence on exercise is consistent: regular, appropriately guided activity builds periarticular muscle around the knee and hip, reducing the load cartilage absorbs with each step. NHS guidance identifies exercise as one of the highest-impact available actions, and clinical evidence confirms it does not worsen osteoarthritis symptoms when correctly guided. Weight management carries similar weight. Even modest reductions in body mass measurably reduce compressive load across joint surfaces — a direct mechanical effect, not a background lifestyle suggestion.

Acute joint injuries deserve particular attention here. Unresolved ligament or meniscal damage is a recognised accelerant of cartilage loss: altered joint mechanics following an untreated injury change how load is distributed, and degeneration can follow. The practical implication is to treat acute injuries actively and early rather than managing through them, since delay — identified by NHS guidance as a specific risk factor for osteoarthritis progression — can compress the window in which preservation remains realistic.

For physically active patients, training load, footwear choice, and movement technique are modifiable. Overuse before adequate healing is an avoidable accelerant.

A practical signal worth acting on: pain or swelling that persists after an acute joint injury rather than improving steadily, or osteoarthritis symptoms that do not settle after a sustained period of consistent exercise, both warrant specialist review before waiting for symptoms to worsen. The preservation window is not indefinite, and assessment while damage is still focal keeps the full treatment range open.

Getting assessed before your options narrow

Timing matters more than patients often realise. A specialist preservation assessment is most valuable before the disease reaches the point where diffuse, bone-on-bone changes have already foreclosed the techniques described in earlier sections — not afterwards. Once Kellgren–Lawrence grade 4 change is established across the whole joint, the honest answer is usually replacement; the window in which repair or regeneration remains realistic sits earlier than that, and acting within it keeps the full range of options open.

Assessment at this stage involves imaging review — typically MRI to characterise defect size, location, and the quality of the surrounding cartilage and subchondral bone — alongside clinical evaluation of alignment, stability, and function. These findings together determine where on the preservation-to-replacement spectrum a patient currently sits and which specific techniques, if any, are realistic candidates.

Patients who have been told that replacement is their only option have not always reached that conclusion after a full preservation evaluation. Seeking a specialist second opinion is appropriate, particularly where the diagnosis involves a focal lesion rather than diffuse end-stage disease — the distinction that determines whether preservation remains a genuine path.

At London Cartilage Clinic on Harley Street, Professor Paul Y. F. Lee leads cartilage and joint-preservation assessment for suitable patients. A single consultation to map the current state of the joint is a low-commitment way to clarify what is still possible — appointments are available at londoncartilage.com.

1. [1] Osteoarthritis – NHS. https://www.nhs.uk/conditions/osteoarthritis/ https://www.nhs.uk/conditions/osteoarthritis/
2. [2] Osteoarthritis – Wikipedia. https://en.wikipedia.org/?curid=504841 https://en.wikipedia.org/?curid=504841